113 related articles for article (PubMed ID: 20331368)
1. Gray zone lymphomas in pediatric patients.
Liang X; Greffe B; Cook B; Giller R; Graham DK; McGranahan AN; Wang M
Pediatr Dev Pathol; 2011; 14(1):57-63. PubMed ID: 20331368
[TBL] [Abstract][Full Text] [Related]
2. B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology.
Carbone A; Gloghini A; Aiello A; Testi A; Cabras A
Hum Pathol; 2010 May; 41(5):621-31. PubMed ID: 20398809
[TBL] [Abstract][Full Text] [Related]
3. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Burkitt's lymphoma: A case report and review.
Chettiankandy TJ; Tupkari JV; Kumar K; Ahire MS
J Oral Maxillofac Pathol; 2016; 20(2):333. PubMed ID: 27601842
[TBL] [Abstract][Full Text] [Related]
4. [Primary mediastinal B-cell lymphoma].
Coso D; Rey J; Bouabdallah R
Rev Pneumol Clin; 2010 Feb; 66(1):32-5. PubMed ID: 20207294
[TBL] [Abstract][Full Text] [Related]
5. Pathology consultation on intermediate-to-large B-cell lymphomas.
Montgomery ND; Fedoriw Y
Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
7. New REAL clinical entities.
Fisher RI; Miller TP; Grogan TM
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
[TBL] [Abstract][Full Text] [Related]
8. Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach.
Bellan C; Stefano L; Giulia de F; Rogena EA; Lorenzo L
Hematol Oncol; 2009 Dec; 27(4):182-5. PubMed ID: 19670467
[TBL] [Abstract][Full Text] [Related]
9. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
11. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous B-cell lymphoma: classification and treatment.
Willemze R
Curr Opin Oncol; 2006 Sep; 18(5):425-31. PubMed ID: 16894288
[TBL] [Abstract][Full Text] [Related]
13. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
14. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
Soslow RA; Baergen RN; Warnke RA
Cancer; 1999 Jun; 85(12):2648-54. PubMed ID: 10375114
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Gualco G; Natkunam Y; Bacchi CE
Mod Pathol; 2012 May; 25(5):661-74. PubMed ID: 22222636
[TBL] [Abstract][Full Text] [Related]
16. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
18. How I manage patients with grey zone lymphoma.
Kritharis A; Pilichowska M; Evens AM
Br J Haematol; 2016 Aug; 174(3):345-50. PubMed ID: 27301470
[TBL] [Abstract][Full Text] [Related]
19. Primary cardiac lymphoma: clinical, histologic, immunophenotypic, and genotypic features of 5 cases of a rare disorder.
Nascimento AF; Winters GL; Pinkus GS
Am J Surg Pathol; 2007 Sep; 31(9):1344-50. PubMed ID: 17721189
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
